The Role of Posttranslational Modification and Mitochondrial Quality Control in Cardiovascular Diseases | Zendy

Jinlin Liu | Zendy; Li Zhong | Zendy; Rui Guo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Role of Posttranslational Modification and Mitochondrial Quality Control in Cardiovascular Diseases

Author(s) -

Jinlin Liu,

Li Zhong,

Rui Guo

Publication year - 2021

Publication title -

oxidative medicine and cellular longevity

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.494

H-Index - 93

eISSN - 1942-0900

pISSN - 1942-0994

DOI - 10.1155/2021/6635836

Subject(s) - mechanism (biology) , mitochondrion , function (biology) , disease , posttranslational modification , pathogenesis , biology , microbiology and biotechnology , bioinformatics , medicine , biochemistry , enzyme , immunology , philosophy , epistemology

Cardiovascular disease (CVD) is the leading cause of death in the world. The mechanism behind CVDs has been studied for decades; however, the pathogenesis is still controversial. Mitochondrial homeostasis plays an essential role in maintaining the normal function of the cardiovascular system. The alterations of any protein function in mitochondria may induce abnormal mitochondrial quality control and unexpected mitochondrial dysfunction, leading to CVDs. Posttranslational modifications (PTMs) affect protein function by reversibly changing their conformation. This review summarizes how common and novel PTMs influence the development of CVDs by regulating mitochondrial quality control. It provides not only ideas for future research on the mechanism of some types of CVDs but also ideas for CVD treatments with therapeutic potential.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research